Literature DB >> 33268857

The race to deliver the hypoallergenic cat.

Amber Dance.   

Abstract

Keywords:  Animal behaviour; Human behaviour; Immunology; Personalized medicine

Year:  2020        PMID： 33268857     DOI： 10.1038/d41586-020-02779-3

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  9 in total

1.  Expression and genomic structure of the genes encoding FdI, the major allergen from the domestic cat.

Authors:  I J Griffith; S Craig; J Pollock; X B Yu; J P Morgenstern; B L Rogers
Journal:  Gene       Date:  1992-04-15       Impact factor: 3.688

2.  Sensitization and Exposure to Pets: The Effect on Asthma Morbidity in the US Population.

Authors:  Peter J Gergen; Herman E Mitchell; Agustin Calatroni; Michelle L Sever; Richard D Cohn; Pӓivi M Salo; Peter S Thorne; Darryl C Zeldin
Journal:  J Allergy Clin Immunol Pract       Date:  2017-07-08

3.  Treatment with grass allergen peptides improves symptoms of grass pollen-induced allergic rhinoconjunctivitis.

Authors:  Anne K Ellis; Charles W Frankish; Robyn E O'Hehir; Kristen Armstrong; Lisa Steacy; Mark Larché; Roderick P Hafner
Journal:  J Allergy Clin Immunol       Date:  2017-02-21       Impact factor: 10.793

4.  Fel d 1-derived synthetic peptide immuno-regulatory epitopes show a long-term treatment effect in cat allergic subjects.

Authors:  P Couroux; D Patel; K Armstrong; M Larché; R P Hafner
Journal:  Clin Exp Allergy       Date:  2015-05       Impact factor: 5.018

5.  Immunization of cats to induce neutralizing antibodies against Fel d 1, the major feline allergen in human subjects.

Authors:  Franziska Thoms; Gary T Jennings; Melanie Maudrich; Monique Vogel; Stefanie Haas; Andris Zeltins; Regina Hofmann-Lehmann; Barbara Riond; Jonas Grossmann; Peter Hunziker; Antonia Fettelschoss-Gabriel; Gabriela Senti; Thomas M Kündig; Martin F Bachmann
Journal:  J Allergy Clin Immunol       Date:  2019-05-02       Impact factor: 10.793

6.  Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy.

Authors:  Nicole Schmitz; Klaus Dietmeier; Monika Bauer; Melanie Maudrich; Stefan Utzinger; Simone Muntwiler; Philippe Saudan; Martin F Bachmann
Journal:  J Exp Med       Date:  2009-08-10       Impact factor: 14.307

7.  Treating cat allergy with monoclonal IgG antibodies that bind allergen and prevent IgE engagement.

Authors:  J M Orengo; A R Radin; V Kamat; A Badithe; L H Ben; B L Bennett; S Zhong; D Birchard; A Limnander; A Rafique; J Bautista; A Kostic; D Newell; X Duan; M C Franklin; W Olson; T Huang; N A Gandhi; L Lipsich; N Stahl; N J Papadopoulos; A J Murphy; G D Yancopoulos
Journal:  Nat Commun       Date:  2018-04-12       Impact factor: 14.919

8.  Reduction of active Fel d1 from cats using an antiFel d1 egg IgY antibody.

Authors:  Ebenezer Satyaraj; Cari Gardner; Ivan Filipi; Kerry Cramer; Scott Sherrill
Journal:  Immun Inflamm Dis       Date:  2019-03-09

9.  Multi-Level Safety Studies of Anti Fel d 1 IgY Ingredient in Cat Food.

Authors:  Ray A Matulka; Larry Thompson; David Corley
Journal:  Front Vet Sci       Date:  2020-01-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.